Loading financial statements…
Import this data to Google Sheets with:
=jivedata("BCTXW","financials")Full statements spill as a table. For one cell: =jivedata("BCTXW","Revenue") or =jivedata("BCTXW","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
BCTXW • CIK 0001610820
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Research and Development Expense | $15,336.638 | $27,177.807 | $21,270.678 | $25,814.369 |
| General and Administrative Expense | $7,935.626 | $6,152.269 | $5,934.125 | $6,214.907 |
| Operating Income (Loss) | $-23,272.264 | $-33,330.076 | $-27,204.803 | $-32,029.276 |
| Operating Expenses | — | $33,330.076 | $27,204.803 | $32,029.276 |
| Nonoperating Income (Expense) | $2,969.87 | $262.566 | $114.511 | $475.406 |
| Fair Value Adjustment of Warrants | $-2,119.53 | $-28,242.472 | $-758.364 | $-658.158 |
| Income (Loss) from Equity Method Investments | — | $-106.51 | $-224.212 | $-218.501 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | $-4,931.548 | $-26,556.14 | $-30,976.383 |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | $-140.082 | $-244.273 | $-301.121 |
| Net Income (Loss) Attributable to Parent | $-20,302.394 | $-4,791.466 | $-26,311.867 | $-30,675.262 |
| Weighted Average Number of Shares Outstanding, Basic | 15,619,676 | 16,454,932 | 423,114 | 1,648,146 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $21,251.092 | $862.089 | $10,493.808 | $6,880.221 |
| Short-term Investments | — | — | $7,372.473 | $15,924.204 |
| Assets | $27,163.577 | $5,872.261 | $21,649.706 | $27,071.31 |
| Assets, Current | $26,948.507 | $3,653.854 | $19,926.576 | $25,393.174 |
| EquitySecuritiesFVNINoncurrent | — | $418.49 | $524.278 | $750.982 |
| Intangible Assets, Net (Excluding Goodwill) | — | $199.796 | $184.525 | $180.707 |
| Property, Plant and Equipment, Net | $2.5 | $388.175 | $296.819 | $348.997 |
| Prepaid Expense, Noncurrent | — | $1,211.946 | $717.508 | $405.085 |
| Assets, Noncurrent | $215.07 | $2,218.407 | $1,723.13 | $1,678.136 |
| Accounts Payable, Trade, Current | $1,123.739 | $7,170.781 | $3,283.703 | $2,174.437 |
| Accounts Payable and Other Accrued Liabilities, Current | $677.718 | $290.376 | $694.285 | $1,416.059 |
| Liabilities, Current | $1,801.457 | $7,461.157 | $3,977.988 | $3,590.496 |
| Derivative Liability, Noncurrent | — | $1,096.036 | $337.672 | $71.854 |
| Liabilities, Noncurrent | $29,139.301 | $1,096.036 | $337.672 | $71.854 |
| Common Stock, Value, Issued | $69,591.784 | $72,166.414 | $101,739.923 | $117,117.225 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-138.684 | $-138.684 | $-138.684 | $-138.684 |
| Stockholders' Equity Attributable to Noncontrolling Interest | — | $-302.522 | $-546.795 | $-649.099 |
| Retained Earnings (Accumulated Deficit) | $-80,652.231 | $-85,443.697 | $-111,755.564 | $-134,339.456 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | — | $-2,684.932 | $17,334.046 | $23,408.96 |
| Common Stock, Shares, Issued | 15,981,726 | 18,284,661 | 1,883,906 | 7,250,487 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | $-4,931.548 | $-26,556.14 | $-30,976.383 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | $-20,389.003 | $9,631.719 | $-5,580.032 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $862.089 | $10,493.808 | $7,415.555 |
| Amortization | $15.271 | $15.271 | $15.271 | $15.271 |
| Payments to Acquire Property, Plant, and Equipment | — | $456.801 | $456.801 | — |
| Unrealized Gain (Loss) on Investments | — | — | $56.473 | $56.473 |
| Payments to Acquire Short-term Investments | — | — | $7,316 | $7,316 |
| Depreciation | — | $68.626 | $91.356 | $97.71 |
| Payments to Acquire Investments | — | $225 | $330 | $335 |
| Share-based Payment Arrangement, Noncash Expense | $2,193.79 | $1,804.078 | $776.879 | $1,012.749 |
| Net Cash Provided by (Used in) Investing Activities | — | $-681.801 | $-7,646 | $-16,186.576 |
| Income (Loss) from Equity Method Investments | — | $-106.51 | $-224.212 | $-218.501 |
| Fair Value Adjustment of Warrants | $-2,119.53 | $-28,242.472 | $-758.364 | $-658.158 |
| Net Cash Provided by (Used in) Operating Activities | $-23,744.86 | $-24,126.128 | $-28,170.52 | $-30,824.897 |
| Proceeds from Warrant Exercises | $1.594 | $1.594 | $821.015 | $821.015 |
| Proceeds from Issuance of Common Stock | $4,000 | $4,418.926 | $44,627.224 | $41,431.441 |
| Net Cash Provided by (Used in) Financing Activities | $3,954.3 | $4,418.926 | $45,448.239 | $41,431.441 |
| Increase (Decrease) in Accounts Receivable | $-5.23 | $732.578 | $-733.629 | $-733.629 |
| Increase (Decrease) in Prepaid Expense | $4,397.597 | $-2,126.282 | $-492.279 | $-492.279 |
| Increase (Decrease) in Accounts Payable | $660.459 | $6,047.042 | $-3,887.078 | $-1,104.767 |
| Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | $199.911 | $-387.339 | $753.909 | $364.63 |